Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kevin Shawn Oh, M.D.


Involved-field radiation therapy for metastases to the posterior fossa
Summer, 06/14/10 - 08/06/10

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Saraf A, Yock TI, Niemierko A, Oh KS, Curry WT, Butler WE, Forst DA, Arrillaga-Romany I, Ebb DH, Tarbell NJ, MacDonald S, Loeffler JS, Shih HA. Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience. Neuro Oncol. 2022 12 01; 24(12):2180-2189. PMID: 35671386; PMCID: PMC9713502.
    Citations:    Fields:    
  2. Brastianos PK, Strickland MR, Lee EQ, Wang N, Cohen JV, Chukwueke U, Forst DA, Eichler A, Overmoyer B, Lin NU, Chen WY, Bardia A, Juric D, Dagogo-Jack I, White MD, Dietrich J, Nayyar N, Kim AE, Alvarez-Breckenridge C, Mahar M, Mora JL, Nahed BV, Jones PS, Shih HA, Gerstner ER, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nat Commun. 2021 10 12; 12(1):5954. PMID: 34642329.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  3. White MD, Klein RH, Shaw B, Kim A, Subramanian M, Mora JL, Giobbie-Hurder A, Nagabhushan D, Jain A, Singh M, Kuter BM, Nayyar N, Bertalan MS, Stocking JH, Markson SC, Lastrapes M, Alvarez-Breckenridge C, Cahill DP, Gydush G, Rhoades J, Rotem D, Adalsteinsson VA, Mahar M, Kaplan A, Oh K, Sullivan RJ, Gerstner E, Carter SL, Brastianos PK. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid. JAMA Netw Open. 2021 08 02; 4(8):e2120040. PMID: 34369989.
    Citations: 5     Fields:    Translation:Humans
  4. Massaad E, Saylor PJ, Hadzipasic M, Kiapour A, Oh K, Schwab JH, Schoenfeld AJ, Shankar GM, Shin JH. The effectiveness of systemic therapies after surgery for metastatic renal cell carcinoma to the spine: a propensity analysis controlling for sarcopenia, frailty, and nutrition. J Neurosurg Spine. 2021 Jun 25; 1-10. PMID: 34171829.
    Citations: 1     Fields:    
  5. Shankar GM, Van Beaver LA, Choi BD, Hadzipasic M, Sivaganesan A, Karhade AV, Ferrone ML, Harris MB, Schoenfeld AJ, Sadow PM, Oh K, Schwab JH, Saylor PJ, Shin JH. Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes. Neurosurgery. 2020 11 16; 87(6):1174-1180. PMID: 32521012.
    Citations: 1     Fields:    Translation:Humans
  6. Starkweather CK, Choi BD, Alvarez-Breckenridge C, Brastianos PK, Oh K, Wang N, Shih H, Nahed BV. Initial Approach to the Patient with Multiple Newly Diagnosed Brain Metastases. Neurosurg Clin N Am. 2020 Oct; 31(4):505-513. PMID: 32921347.
    Citations:    Fields:    Translation:Humans
  7. Lee G, Lamba N, Niemierko A, Kim DW, Chapman PH, Loeffler JS, Curry WT, Martuza RL, Oh KS, Barker FG, Shih HA. Adjuvant Radiation Therapy Versus Surveillance After Surgical Resection of Atypical Meningiomas. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):252-266. PMID: 32777336.
    Citations: 9     Fields:    Translation:Humans
  8. Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 Aug; 26(8):1309. PMID: 32555425.
    Citations: 1     Fields:    
  9. Massaad E, Hadzipasic M, Alvarez-Breckenridge C, Kiapour A, Fatima N, Schwab JH, Saylor P, Oh K, Schoenfeld AJ, Shankar GM, Shin JH. Predicting tumor-specific survival in patients with spinal metastatic renal cell carcinoma: which scoring system is most accurate? J Neurosurg Spine. 2020 Jun 05; 1-11. PMID: 32502990.
    Citations: 1     Fields:    
  10. Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 08; 26(8):1280-1284. PMID: 32483359.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  11. Lebow ES, Hwang WL, Zieminski S, Wang Y, Niemierko A, Mehan WA, Oh KS, Khandekar M, Willers H, Shih HA. Early experience with hippocampal avoidance whole brain radiation therapy and simultaneous integrated boost for brain metastases. J Neurooncol. 2020 May; 148(1):81-88. PMID: 32307637.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  12. Byrne JD, Botticello T, Niemierko A, Shih HA, Loeffler JS, Oh KS. Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases. Sci Rep. 2020 04 14; 10(1):6331. PMID: 32286375.
    Citations: 1     Fields:    Translation:Humans
  13. Cohen JV, Wang N, Venur VA, Hadfield MJ, Cahill DP, Oh K, Brastianos PK. Neurologic complications of melanoma. Cancer. 2020 02 01; 126(3):477-486. PMID: 31725902.
    Citations:    Fields:    Translation:Humans
  14. McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV. Cancer Med. 2020 01; 9(1):3-11. PMID: 31701682.
    Citations: 7     Fields:    Translation:HumansCells
  15. Koch MJ, Agarwalla PK, Royce TJ, Shih HA, Oh K, Niemierko A, Mauceri TC, Curry WT, Barker FG, Loeffler JS. Brachytherapy as an Adjuvant for Recurrent Atypical and Malignant Meningiomas. Neurosurgery. 2019 11 01; 85(5):E910-E916. PMID: 31329941; PMCID: PMC7308736.
    Citations: 8     Fields:    Translation:Humans
  16. Lamba N, Hwang WL, Kim DW, Niemierko A, Marciscano AE, Mehan WA, Benayoun MD, Curry WT, Barker FG, Martuza RL, Dunn IF, Claus E, Bi WL, Aizer AA, Alexander BM, Oh KS, Loeffler JS, Shih HA. Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional Analysis. World Neurosurg. 2020 Jan; 133:e804-e812. PMID: 31605839.
    Citations: 1     Fields:    Translation:Humans
  17. Karhade AV, Thio QCBS, Ogink PT, Bono CM, Ferrone ML, Oh KS, Saylor PJ, Schoenfeld AJ, Shin JH, Harris MB, Schwab JH. Predicting 90-Day and 1-Year Mortality in Spinal Metastatic Disease: Development and Internal Validation. Neurosurgery. 2019 10 01; 85(4):E671-E681. PMID: 30869143.
    Citations: 30     Fields:    Translation:Humans
  18. Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S, Adams J, Kim V, Oh KS, Hwang WL, Lu HM, Belka C, Busse PM, Loeffler JS, Shih HA. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. Radiother Oncol. 2020 01; 142:154-161. PMID: 31563411.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  19. Karhade AV, Thio QCBS, Ogink PT, Shah AA, Bono CM, Oh KS, Saylor PJ, Schoenfeld AJ, Shin JH, Harris MB, Schwab JH. Development of Machine Learning Algorithms for Prediction of 30-Day Mortality After Surgery for Spinal Metastasis. Neurosurgery. 2019 07 01; 85(1):E83-E91. PMID: 30476188.
    Citations: 28     Fields:    Translation:Humans
  20. Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, Fullerton BC, Daartz J, Royce TJ, Oh KS, Batchelor TT, Curry WT, Loeffler JS, Shih HA. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019 08; 137:95-101. PMID: 31082632.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  21. Alvarez-Breckenridge C, Giobbie-Hurder A, Gill CM, Bertalan M, Stocking J, Kaplan A, Nayyar N, Lawrence DP, Flaherty KT, Shih HA, Oh K, Batchelor TT, Cahill DP, Sullivan R, Brastianos PK. Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control. Oncologist. 2019 05; 24(5):671-679. PMID: 30796152.
    Citations: 13     Fields:    Translation:Humans
  22. Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, Shih HA. Patterns of Failure Among Patients With Low-grade Glioma Treated With Proton Radiation Therapy. Pract Radiat Oncol. 2019 Jul - Aug; 9(4):e356-e361. PMID: 30790717.
    Citations: 3     Fields:    Translation:Humans
  23. Lamba N, Bussiere MR, Niemierko A, Abedi P, Fullerton BC, Loeffler JS, Oh KS, Nachtigall LB, Shih HA. Hypopituitarism After Cranial Irradiation for Meningiomas: A Single-Institution Experience. Pract Radiat Oncol. 2019 May; 9(3):e266-e273. PMID: 30731274.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  24. Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77. PMID: 30488294.
    Citations: 12     Fields:    Translation:Humans
  25. Choi BD, Shankar GM, Sivaganesan A, Van Beaver LA, Oh K, Shin JH. Implication of Biomarker Mutations for Predicting Survival in Patients With Metastatic Lung Cancer to the Spine. Spine (Phila Pa 1976). 2018 Nov 01; 43(21):E1274-E1280. PMID: 29652780.
    Citations: 3     Fields:    Translation:HumansCells
  26. Mitra D, Clark JW, Shih HA, Oh KS, Brastianos PK, Wo JY, Strickland MR, Curry WT, Parikh AR, Corcoran RB, Ryan DP, Iafrate AJ, Borger DR, Lennerz JK, Hong TS. Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies. Oncologist. 2019 02; 24(2):193-201. PMID: 30373904; PMCID: PMC6369954.
    Citations: 4     Fields:    Translation:Humans
  27. Johnson SB, Hung J, Kapadia N, Oh KS, Kim M, Hamstra DA. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma. Pract Radiat Oncol. 2019 Jan; 9(1):e22-e28. PMID: 30036592.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  28. Wang Y, Rapalino O, Heidari P, Loeffler J, Shih HA, Oh K, Mahmood U. C11 Methionine PET (MET-PET) Imaging of Glioblastoma for Detecting Postoperative Residual Disease and Response to Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1024-1028. PMID: 29913253; PMCID: PMC7336810.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  29. Kim J, Park YK, Edmunds D, Oh K, Sharp GC, Winey B. Kilovoltage projection streaming-based tracking application (KiPSTA): First clinical implementation during spine stereotactic radiation surgery. Adv Radiat Oncol. 2018 Oct-Dec; 3(4):682-692. PMID: 30370370; PMCID: PMC6200888.
    Citations: 2     
  30. Atkins KM, Pashtan IM, Bussière MR, Kang KH, Niemierko A, Daly JE, Botticello TM, Hurd MC, Chapman PH, Oh K, Loeffler JS, Shih HA. Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):820-829. PMID: 29976494.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  31. Schapira E, Hubbeling H, Yeap BY, Mehan WA, Shaw AT, Oh K, Gainor JF, Shih HA. Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):624-629. PMID: 29678530.
    Citations: 42     Fields:    Translation:Humans
  32. Rahman R, Cortes A, Niemierko A, Oh KS, Flaherty KT, Lawrence DP, Sullivan RJ, Shih HA. The impact of timing of immunotherapy with cranial irradiation in melanoma patients with brain metastases: intracranial progression, survival and toxicity. J Neurooncol. 2018 Jun; 138(2):299-306. PMID: 29453679.
    Citations: 17     Fields:    Translation:Humans
  33. Hubbeling HG, Schapira EF, Horick NK, Goodwin KEH, Lin JJ, Oh KS, Shaw AT, Mehan WA, Shih HA, Gainor JF. Safety of Combined PD-1 Pathway Inhibition and Intracranial Radiation Therapy in Non-Small Cell Lung Cancer. J Thorac Oncol. 2018 04; 13(4):550-558. PMID: 29378267.
    Citations: 45     Fields:    Translation:Humans
  34. Soliman H, Ruschin M, Angelov L, Brown PD, Chiang VLS, Kirkpatrick JP, Lo SS, Mahajan A, Oh KS, Sheehan JP, Soltys SG, Sahgal A. Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):436-442. PMID: 29157748.
    Citations: 44     Fields:    Translation:Humans
  35. Kim D, Niemierko A, Hwang WL, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Oh KS, Loeffler JS, Shih HA. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas. J Neurosurg. 2018 04; 128(4):1123-1132. PMID: 28621619.
    Citations: 17     Fields:    Translation:Humans
  36. Shankar GM, Choi BD, Grannan BL, Oh K, Shin JH. Effect of Immunotherapy Status on Outcomes in Patients With Metastatic Melanoma to the Spine. Spine (Phila Pa 1976). 2017 Jun 15; 42(12):E721-E725. PMID: 27879568.
    Citations: 3     Fields:    Translation:Humans
  37. Jimenez RB, Alexander BM, Mahadevan A, Niemierko A, Rajakesari S, Arvold ND, Floyd SR, Oh KS, Loeffler JS, Shih HA. The impact of different stereotactic radiation therapy regimens for brain metastases on local control and toxicity. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):391-397. PMID: 29114607; PMCID: PMC5605319.
    Citations: 7     
  38. Hashmi A, Guckenberger M, Kersh R, Gerszten PC, Mantel F, Grills IS, Flickinger JC, Shin JH, Fahim DK, Winey B, Oh K, John Cho BC, Létourneau D, Sheehan J, Sahgal A. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis. J Neurosurg Spine. 2016 Nov; 25(5):646-653. PMID: 27341054.
    Citations: 26     Fields:    Translation:Humans
  39. Jawad MS, Fahim DK, Gerszten PC, Flickinger JC, Sahgal A, Grills IS, Sheehan J, Kersh R, Shin J, Oh K, Mantel F, Guckenberger M. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation. J Neurosurg Spine. 2016 Jun; 24(6):928-36. PMID: 26895526.
    Citations: 21     Fields:    Translation:Humans
  40. Sherman JC, Colvin MK, Mancuso SM, Batchelor TT, Oh KS, Loeffler JS, Yeap BY, Shih HA. Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol. 2016 Jan; 126(1):157-164. PMID: 26498439.
    Citations: 16     Fields:    Translation:Humans
  41. Gainor JF, Chi AS, Logan J, Hu R, Oh KS, Brastianos PK, Shih HA, Shaw AT. Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib. J Thorac Oncol. 2016 Feb; 11(2):256-60. PMID: 26845119.
    Citations: 19     Fields:    Translation:Humans
  42. Hwang WL, Marciscano AE, Niemierko A, Kim DW, Stemmer-Rachamimov AO, Curry WT, Barker FG, Martuza RL, Loeffler JS, Oh KS, Shih HA, Larvie M. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade. Neuro Oncol. 2016 06; 18(6):863-72. PMID: 26597949; PMCID: PMC4864259.
    Citations: 33     Fields:    Translation:Humans
  43. Nahed BV, Redjal N, Brat DJ, Chi AS, Oh K, Batchelor TT, Ryken TC, Kalkanis SN, Olson JJ. Management of patients with recurrence of diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2015 Dec; 125(3):609-30. PMID: 26530264.
    Citations: 15     Fields:    Translation:Humans
  44. Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, Larvie M, Curry WT, Barker FG, Martuza RL, McGuone D, Oh KS, Loeffler JS, Shih HA. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg. 2016 Jan; 124(1):106-14. PMID: 26274991.
    Citations: 27     Fields:    Translation:Humans
  45. Oh KS, Loeffler JS. The Changing Landscape of Whole-Brain Radiation Therapy. JAMA Oncol. 2015 Jul; 1(4):464-5. PMID: 26181255.
    Citations:    Fields:    Translation:Humans
  46. Wargo JA, Reuben A, Cooper ZA, Oh KS, Sullivan RJ. Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy. Semin Oncol. 2015 Aug; 42(4):601-16. PMID: 26320064; PMCID: PMC4955940.
    Citations: 59     Fields:    Translation:Humans
  47. Wattson DA, Sullivan RJ, Niemierko A, Merritt RM, Lawrence DP, Oh KS, Flaherty KT, Shih HA. Survival patterns following brain metastases for patients with melanoma in the MAP-kinase inhibitor era. J Neurooncol. 2015 May; 123(1):75-84. PMID: 25864098.
    Citations: 4     Fields:    Translation:Humans
  48. Walston S, Hamstra DA, Oh K, Woods G, Guiou M, Olshefski RS, Chakravarti A, Williams TM. A multi-institutional experience in pediatric high-grade glioma. Front Oncol. 2015; 5:28. PMID: 25741472; PMCID: PMC4332307.
    Citations: 8     
  49. Shih HA, Sherman JC, Nachtigall LB, Colvin MK, Fullerton BC, Daartz J, Winrich BK, Batchelor TT, Thornton LT, Mancuso SM, Saums MK, Oh KS, Curry WT, Loeffler JS, Yeap BY. Proton therapy for low-grade gliomas: Results from a prospective trial. Cancer. 2015 May 15; 121(10):1712-9. PMID: 25585890.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  50. Choy E, Attar EC, Oh KS, Huang AJ, Kerr DA. Case records of the Massachusetts General Hospital. Case 33-2014. A 60-year-old man with bone pain. N Engl J Med. 2014 Oct 23; 371(17):1630-40. PMID: 25337753.
    Citations:    Fields:    Translation:Humans
  51. Mak KS, Gainor JF, Niemierko A, Oh KS, Willers H, Choi NC, Loeffler JS, Sequist LV, Shaw AT, Shih HA. Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastases. Neuro Oncol. 2015 Feb; 17(2):296-302. PMID: 25053852.
    Citations: 33     Fields:    Translation:Humans
  52. Chen H, Winey BA, Daartz J, Oh KS, Shin JH, Gierga DP. Efficiency gains for spinal radiosurgery using multicriteria optimization intensity modulated radiation therapy guided volumetric modulated arc therapy planning. Pract Radiat Oncol. 2015 Jan-Feb; 5(1):49-55. PMID: 25413420.
    Citations: 1     Fields:    Translation:Humans
  53. Pashtan I, Oh KS, Loeffler JS. Radiation therapy in the management of pituitary adenomas. Handb Clin Neurol. 2014; 124:317-24. PMID: 25248596.
    Citations: 2     Fields:    Translation:HumansAnimals
  54. Aizer AA, Ancukiewicz M, Nguyen PL, Shih HA, Loeffler JS, Oh KS. Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer. 2014 Jan 15; 120(2):238-43. PMID: 24122361.
    Citations: 17     Fields:    Translation:Humans
  55. Aizer AA, Ancukiewicz M, Nguyen PL, Macdonald SM, Yock TI, Tarbell NJ, Shih HA, Loeffler JS, Oh KS. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol. 2013 Dec; 115(3):411-9. PMID: 24057324.
    Citations: 9     Fields:    Translation:Humans
  56. Brastianos PK, Curry WT, Oh KS. Clinical discussion and review of the management of brain metastases. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1153-64. PMID: 24029127.
    Citations: 16     Fields:    Translation:Humans
  57. Sullivan RJ, Lawrence DP, Wargo JA, Oh KS, Gonzalez RG, Piris A. Case records of the Massachusetts General Hospital. Case 21-2013. A 68-year-old man with metastatic melanoma. N Engl J Med. 2013 Jul 11; 369(2):173-83. PMID: 23841733.
    Citations: 11     Fields:    Translation:HumansCells
  58. Gerszten PC, Sahgal A, Sheehan JP, Kersh R, Chen S, Flickinger JC, Quader M, Fahim D, Grills I, Shin JH, Winey B, Oh K, Sweeney RA, Guckenberger M. A multi-national report on methods for institutional credentialing for spine radiosurgery. Radiat Oncol. 2013 Jun 27; 8:158. PMID: 23806078.
    Citations: 3     Fields:    Translation:Humans
  59. Arvold ND, Oh KS, Niemierko A, Taghian AG, Lin NU, Abi-Raad RF, Sreedhara M, Harris JR, Alexander BM. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype. Breast Cancer Res Treat. 2012 Nov; 136(1):153-60. PMID: 22968656.
    Citations: 43     Fields:    Translation:Humans
  60. Coumans JV, Walcott BP, Nahed BV, Oh KS, Chi AS. Multimodal therapy of an intramedullary cervical primitive neuroectodermal tumor in an adult. J Clin Oncol. 2012 Jan 10; 30(2):e15-8. PMID: 22147740.
    Citations: 5     Fields:    Translation:Humans
  61. Son CH, Jimenez R, Niemierko A, Loeffler JS, Oh KS, Shih HA. Outcomes after whole brain reirradiation in patients with brain metastases. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):e167-72. PMID: 21620583.
    Citations: 28     Fields:    Translation:Humans
  62. Oh KS, Hung J, Robertson PL, Garton HJ, Muraszko KM, Sandler HM, Hamstra DA. Outcomes of multidisciplinary management in pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e481-8. PMID: 21470783.
    Citations: 12     Fields:    Translation:Humans
  63. Oh KS, Soto DE, Smith DC, Montie JE, Lee CT, Sandler HM. Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):511-7. PMID: 18977098.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  64. Oh KS, Sandler HM. CounterPoint: second malignancies after radiotherapy for prostate cancer: keeping perspective. Urology. 2008 Nov; 72(5):971-3. PMID: 18817957.
    Citations:    Fields:    Translation:Humans
  65. Oh KS, Kong FM, Griffith KA, Yanke B, Pierce LJ. Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):680-6. PMID: 16863683.
    Citations: 23     Fields:    Translation:Humans
  66. Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S, Roberts MV, Lucas PC, Oh K, Koker M, Sabel MS, Newman LA. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg. 2005 Oct; 190(4):543-50. PMID: 16164917.
    Citations: 55     Fields:    Translation:Humans
  67. Degnim AC, Oh K, Cimmino VM, Diehl KM, Chang AE, Newman LA, Sabel MS. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram? Ann Surg Oncol. 2005 Sep; 12(9):712-7. PMID: 16079955.
    Citations: 3     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Oh's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (231)
Co-Authors (103)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.